← Back to Search

Gas

Oxygen Gas for Inhalation for Respiratory Insufficiency

N/A
Recruiting
Led By Anthony Doufas, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ninety -minute period beginning immediately post-anesthesia.
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of oxygen on post-anesthesia recovery.

Who is the study for?
This trial is for adults in good to moderate health (ASA I-III), with a BMI under 40, who are scheduled for robotic-assisted kidney removal surgery. It's not open to those with chronic lung disease, severe brain/heart/lung conditions, major psychiatric or untreated thyroid issues, chronic pain on opioid treatment, low blood count or significant blood loss during surgery.
What is being tested?
The study tests if breathing high levels of oxygen after general anesthesia helps patients recover their normal breathing faster. Participants will be randomly assigned to receive extra oxygen or not after they wake up from anesthesia and will be monitored for 90 minutes.
What are the potential side effects?
Inhaling high levels of oxygen can sometimes cause dryness or irritation in the throat and lungs. In rare cases, prolonged exposure may lead to lung damage or changes in blood oxygen levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ninety -minute period beginning immediately post-anesthesia.
This trial's timeline: 3 weeks for screening, Varies for treatment, and ninety -minute period beginning immediately post-anesthesia. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Transcutaneous partial pressure of carbon dioxide (TcPCO2)
Secondary study objectives
Apnea / hypopnea index (AHI)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: "Liberal O2 Supplementation"Experimental Treatment1 Intervention
Oxygen administration will be titrated to an SpO2 \> 96%.
Group II: "Conservative O2 Supplementation"Active Control1 Intervention
Oxygen administration will be titrated to a oxyhemoglobin saturation (SpO2) between 90 and 94%.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,474 Previous Clinical Trials
17,501,880 Total Patients Enrolled
Anthony Doufas, MD, PhDPrincipal InvestigatorProfessor, Department of Anesthesiology, Stanford University Medical School
2 Previous Clinical Trials
18 Total Patients Enrolled

Media Library

Oxygen Gas for Inhalation (Gas) Clinical Trial Eligibility Overview. Trial Name: NCT05379673 — N/A
Complications Research Study Groups: "Conservative O2 Supplementation", "Liberal O2 Supplementation"
Complications Clinical Trial 2023: Oxygen Gas for Inhalation Highlights & Side Effects. Trial Name: NCT05379673 — N/A
Oxygen Gas for Inhalation (Gas) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05379673 — N/A
~13 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top